MMSI

SEC source: 0001415889-24-027066 · form4-11182024_081155.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-026485 · form4-11122024_061103.xml · derivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,361

Underlying: Common Stock · 5,361 shares

Expires 2027-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.

SEC source: 0001415889-24-026485 · form4-11122024_061103.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,361

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $102.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-026485 · form4-11122024_061103.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-026373 · form4-11072024_111108.xml · derivative · entry 3

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 20,000 shares

Expires 2026-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/25/2020.

SEC source: 0001415889-24-026373 · form4-11072024_111108.xml · nonDerivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,819

SEC source: 0001415889-24-026373 · form4-11072024_111108.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-026369 · form4-11072024_111103.xml · derivative · entry 6

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.

SEC source: 0001415889-24-026369 · form4-11072024_111103.xml · derivative · entry 5

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.

SEC source: 0001415889-24-026369 · form4-11072024_111103.xml · nonDerivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,361

F2 · balance_after: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.026, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-026369 · form4-11072024_111103.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-026369 · form4-11072024_111103.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · derivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2025-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,391

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,592

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-016475 · form4-06122024_050616.xml · derivative · entry 3

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.

SEC source: 0001415889-24-016475 · form4-06122024_050616.xml · nonDerivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,819

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.325 to $82.185, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-016475 · form4-06122024_050616.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.

SEC source: 0001415889-24-013816 · form4-05202024_090554.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,743

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013815 · form4-05202024_090507.xml · nonDerivative · entry 1

Evans Stephen C. · CIK 0001844301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,657

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013814 · form4-05202024_090510.xml · nonDerivative · entry 1

Carpenter Lonny J · CIK 0001451534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,215

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RS Us) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013813 · form4-05202024_090509.xml · nonDerivative · entry 1

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,688

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013812 · form4-05202024_090557.xml · nonDerivative · entry 3

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,881

F2 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

F1 · balance_after: Reflects a transfer of 3,050 shares on June 8, 2023 held directly by the reporting person to the David K. Floyd Living Trust in a transaction exempt from reporting under Rule 16a-13.

SEC source: 0001415889-24-013811 · form4-05202024_090534.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,391

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013809 · form4-05202024_090532.xml · nonDerivative · entry 1

Perez Silvia · CIK 0002024006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,431

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013806 · form4-05202024_090546.xml · nonDerivative · entry 1

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,657

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-013803 · form4-05202024_090542.xml · nonDerivative · entry 1

Kaiser Laura S. · CIK 0001726511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,743

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-008144 · form4-03152024_100329.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,602

SEC source: 0001415889-24-007857 · form4-03132024_100311.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,007

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.50 to $74.44, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-007857 · form4-03132024_100311.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,186

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.46 to $74.56, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-007315 · form4-03082024_080344.xml · derivative · entry 3

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.

SEC source: 0001415889-24-007315 · form4-03082024_080344.xml · nonDerivative · entry 2

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,223

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.234 to $76.220, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-007315 · form4-03082024_080344.xml · nonDerivative · entry 1

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-007139 · form4-03072024_010300.xml · nonDerivative · entry 5

Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,908

SEC source: 0001415889-24-007255 · form4-03082024_030311.xml · derivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.

SEC source: 0001415889-24-007255 · form4-03082024_030311.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the Reporting Person's exercise of stock options with a cash payment.

SEC source: 0001415889-24-006503 · form4-03052024_050352.xml · derivative · entry 3

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2024-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

SEC source: 0001415889-24-006503 · form4-03052024_050352.xml · nonDerivative · entry 2

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,257

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-006503 · form4-03052024_050352.xml · nonDerivative · entry 1

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-006497 · form4-03052024_030331.xml · nonDerivative · entry 1

Evans Stephen C. · CIK 0001844301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,226

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.34 to $76.35. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-007139 · form4-03072024_010300.xml · nonDerivative · entry 4

Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,223

F4 · shares: Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction,

SEC source: 0001415889-24-007139 · form4-03072024_010300.xml · nonDerivative · entry 3

Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,853

F3 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/19/2021.

SEC source: 0001415889-24-007139 · form4-03072024_010300.xml · nonDerivative · entry 2

Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,743

F2 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-006981 · form4-03062024_050300.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,319

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-006979 · form4-03062024_050350.xml · nonDerivative · entry 3

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,223

F3 · shares: Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction.

SEC source: 0001415889-24-006979 · form4-03062024_050350.xml · nonDerivative · entry 2

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,853

F2 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/19/2021.

SEC source: 0001415889-24-006979 · form4-03062024_050350.xml · nonDerivative · entry 1

Wright Joseph · CIK 0001643713 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,743

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-006977 · form4-03062024_050346.xml · nonDerivative · entry 3

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,782

F3 · shares: Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction.

SEC source: 0001415889-24-006977 · form4-03062024_050346.xml · nonDerivative · entry 2

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,349

F2 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03.19.2021.